Dr. Lal Path Labs Ltd. — Updates, 31-10-2025: General Updates
31-10-2025 | 02:15 pm
31-10-2025 | 02:15 pm
Company's Board approved Q2/H1 financial results, a ₹7 interim dividend, and a 1:1 bonus share issue. Authorized capital increased from ₹107.96 Cr to ₹200 Cr, boosting future equity options.
No comments yet. Be the first to comment!
